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Dear editor,
Frequent participation in physical activity has a positive
impact on individual physical and psychological well-being,
and the effect of physical activity and exercise varies according
to individual physical fitness level, the environment, and drug
intake. Particularly, severe exercise that exceeds the individual
physical fitness level may result in musculoskeletal injury or
damage,1 and rhabdomyolysis is a pathological condition of the
musculoskeletal system that can be complicated by acute renal
failure, compartment syndrome, and hepatitis.2 People who fail
to receive proper management for rhabdomyolysis may face
life-threatening conditions, even death.3
Recent studies4 have reported on a number of cases that
developed myopathy associated with herbal medicines contain-
ingMahuang (ephedra sinica), suggesting the possibility that the
increased activity of the sympathetic nervous system triggered
by the ephedrine contained in ephedra and its derivative ephedra
alkaloids may cause rhabdomyolysis as well as myopathy.5
The maximum dose for ephedra is usually recommended to
be 32 mg/day.6Although the exact dose of ephedra used in herbal
drugs is unknown, we postulate that rhabdomyolysis may be
induced by the herbal medicine. In 2004, theU.S. Food andDrug
Administration banned ephedra-containing products due to
numerous reports of adverse events.7 Nevertheless, the use of
ephedra-containing products is still allowed in Asian countries,
including China and Korea, so the adverse events of its use
should be taken into consideration. To this end, this letter pres-
ents a case of a previously healthy female subject who developed
rhabdomyolysis while exercising and using an herbal medicine
containing ephedra that was marketed to accelerate fat loss.
The 29-year-old female subject (height = 165 cm,
weight = 68 kg) did not have a remarkable history of disease or
a family history of cardiovascular disease. The patient was
performing a regular spinning exercise (Borg’s scale 15: hard
intensity) for weight loss after having taken an herbal medicine
containing ephedra. The woman experienced an unusually
severe pain in her thighs and produced dark urine 48 h after the
exercise.
The first physical examination after being admitted to the
emergency room revealed swelling in her thighs.A neurological
examination and an electrocardiograph presented normal
results. However, some test items in the blood (including elec-
trolytes), biochemical examinations, and urinalysis revealed
abnormal findings associated with rhabdomyolysis (Table 1).
An examination of the blood chemistry revealed liver function
test results consisting of 1728 IU/L in aspartate transaminase
(AST) and 364 IU/L in alanine transaminase (ALT), indicating
the presence of hepatitis.
The patient’s c-reactive protein (CRP), a blood inflamma-
tory marker, was high (1.94 mg/dL). The laboratory findings of
creatinine and K+ were normal, but high levels of creatinine
kinase (CK; 25,010 U/L), myoglobin (MB; 15,510.40 ng/mL),
and CK-MB (206.9 ng/mL) indicated rhabdomyolysis. The
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Table 1
The results of abnormal test results in blood.
Test Value Reference
AST (IU/L) 1728 15–41
ALT (IU/L) 364 4–43
MB (ng/mL) 15,510.40 14.30–65.8l
CK (U/L) 25,010 50–200
CK-MB (ng/mL) 206.9 0.6–6.3
CRP (mg/dL) 1.94 0–0.75
LDH (IU/L) 7370 263–450
Abbreviations: AST = aspartate transaminase; ALT = alanine transaminase;
MB = myoglobin; CK = creatine kinase; CRP = c-reactive protein;
LDH = lactate dehydrogenase.
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patient had a lactate dehydrogenase (LDH) level of 7370 IU/L,
which was 10 times higher than normal. The LDH level is an
indicator of muscular injury. Re-test results 4 days after admis-
sion revealed a normal CRP level but abnormal results in
terms of liver function and blood (AST = 1193 IU/L,
ALT = 468 IU/L, CK = 14,615 U/L, MB = 231.60 ng/mL; and
CK-MB = 27.30 ng/mL).
This case highlights the risk of developing rhabdomyolysis,
even during regular exercise, if herbal drugs containing ephedra
are consumed. In order to exercise more safely, special attention
should be taken in people consuming ephedra during physical
activity. We plan to further investigate the mechanism of
ephedra-induced rhabdomyolysis.
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